Trial Profile
A Continuation Study of TH-CR-406/SARC021 for the Remaining Subjects Enrolled in TH-CR-406/SARC021 in the US
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 22 Mar 2016
Price :
$35
*
At a glance
- Drugs Evofosfamide (Primary)
- Indications Soft tissue sarcoma
- Focus Expanded access; Therapeutic Use
- 22 Mar 2016 New trial record